Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.
Antimicrob Agents Chemother
; 66(5): e0214421, 2022 05 17.
Article
in En
| MEDLINE
| ID: mdl-35404075
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis, Multidrug-Resistant
/
Nitroimidazoles
Type of study:
Prognostic_studies
Limits:
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2022
Type:
Article
Affiliation country:
South Africa